Achieve Life(us:ACHV)
2.51
-5.99%
Updated on 2025-04-02
Open:2.67
Close:2.51
High:2.75
Low:2.48
Prev Close:2.67
Volume:136169.00
Turnover:345005.22
Turnover Ratio:0.39%
Shares:34.69M
MarketCap:87.06M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 63 | 19203004 | 55.92% | 22 | 14 | 17 |
| 2024-03-31 | 48 | 16460395 | 48.06% | 18 | 6 | 16 |
| 2023-12-31 | 38 | 2727593 | 12.89% | 3 | 11 | 16 |
| 2023-09-30 | 42 | 3117219 | 14.73% | 5 | 8 | 20 |
| 2023-06-30 | 42 | 3574232 | 16.93% | 11 | 14 | 13 |
| 2023-03-31 | 36 | 2470554 | 13.78% | 8 | 12 | 11 |
| 2022-12-31 | 33 | 1999767 | 11.17% | 5 | 7 | 13 |
| 2022-09-30 | 34 | 2118966 | 21.89% | 3 | 8 | 16 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Franklin Resources Inc | 5964088 | 17.41% | 5964088 | |
| 2024-03-31 | Propel Bio Management, Llc | 2453092 | 7.16% | 2453092 | |
| 2024-03-31 | Sofinnova Investments, Inc. | 1518230 | 4.43% | 1518230 | |
| 2024-03-31 | Vanguard Group Inc | 948441 | 2.77% | 342731 | 56.58% |
| 2024-03-31 | Adar1 Capital Management, Llc | 875000 | 2.55% | 875000 | |
| 2024-03-31 | Altium Capital Management Lp | 835470 | 2.44% | 835470 | |
| 2024-03-31 | Nantahala Capital Management, Llc | 654000 | 1.91% | 654000 | |
| 2024-03-31 | Cvi Holdings, Llc | 567192 | 1.66% | 567192 | |
| 2024-03-31 | Alyeska Investment Group, L.P. | 471000 | 1.38% | 471000 | |
| 2024-03-31 | Shay Capital Llc | 450000 | 1.31% | -275000 | -37.93% |
About
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
Address:1040 West Georgia Street,Suite 1030
Market Movers